https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg00Diego Alegriahttps://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svgDiego Alegria2024-09-30 11:20:172024-11-12 10:55:48World Cancer Series Innovation Showcase am 01.10.2024
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg00arndslegershttps://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svgarndslegers2024-07-04 10:34:312024-07-04 10:38:47Interview mit Prof. Dr. Volker Schirrmacher im Klassik Radio
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002023-07-28 / Transl Cancer Res 2023 Aug;12(8):2224-2228https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2023-07-28 / Transl Cancer Res 2023 Aug;12(8):2224-22282023-07-28 00:00:002024-04-17 15:08:24Dendritic cell vaccination for glioblastoma multiforme patients: has a new milestone been reached?
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002023-06-23 / Biomedicines 2023 Jun;11(7)https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2023-06-23 / Biomedicines 2023 Jun;11(7)2023-06-23 00:00:002024-04-17 15:04:06The Application of Evidence-Based Medicine in Individualized Medicine
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002023-02-13 / Cancers (Basel) 2023 Feb;15(4)https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2023-02-13 / Cancers (Basel) 2023 Feb;15(4)2023-02-13 00:00:002023-05-30 16:20:40Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience
https://www.iozk.de/wp-content/uploads/2020/11/IOZK_team_van-gool_175828-ret.jpg518690IOZKhttps://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svgIOZK2023-01-23 16:08:352023-01-25 16:42:45Stefaan van Gool ist Herausgeber einer Sonderausgabe im Journal of Molecular Sciences
World Cancer Series Innovation Showcase am 01.10.2024
/in IOZK Aktuelles, IOZK bei Fachtagungen /von Diego AlegriaFachärzte Talk zur kombinierten Immun-Chemotherapie
/in IOZK Aktuelles, IOZK In der Presse /von Diego AlegriaInterview mit Prof. Dr. Volker Schirrmacher im Klassik Radio
/in IOZK Aktuelles, IOZK In der Presse /von arndslegersIndividualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution
/in International Publications, IOZK Aktuelles, IOZK Veröffentlichungen /von 2024-03-28 / Biomedicines 2024 Mar;12(4)Neue IOZK Veröffentlichung zum Thema Liquid Biopsy
/in IOZK Aktuelles, IOZK Veröffentlichungen /von IOZKMethods behind oncolytic virus-based DC vaccines in cancer: Toward a multiphase combined treatment strategy for Glioblastoma (GBM) patients
/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications, IOZK Aktuelles, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2023-10-19 / Methods Cell Biol 2024;183:51-113Dendritic cell vaccination for glioblastoma multiforme patients: has a new milestone been reached?
/in Dendritic Cells, Glioblastoma, International Publications, IOZK Aktuelles, IOZK Veröffentlichungen /von 2023-07-28 / Transl Cancer Res 2023 Aug;12(8):2224-2228The Application of Evidence-Based Medicine in Individualized Medicine
/in International Publications, IOZK Veröffentlichungen /von 2023-06-23 / Biomedicines 2023 Jun;11(7)Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience
/in Dendritic Cells, Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2023-02-13 / Cancers (Basel) 2023 Feb;15(4)Stefaan van Gool ist Herausgeber einer Sonderausgabe im Journal of Molecular Sciences
/in Brain Tumors in Children, IOZK Aktuelles, IOZK Veröffentlichungen /von IOZK